During the open-label extension , all participants received OM @/AML @/HCTZ @ mg ; participants not reaching BP goal within @ weeks were randomly titrated to OM @/AML @/HCTZ @ mg or OM @/AML @/HCTZ @ mg , then to OM @/AML @ / HCTZ @ mg after another @ weeks .